Skip to content
Trial Eligibility
Menu

Macrophage Regulation of Ozone-Induced Lung Inflammation

NCT05773001

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research study to understand how prior respiratory infections affect the susceptibility to lung inflammation following environmental exposures.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Respiratory Viral Infection

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 to 55 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Robert Tighe, MD
Last updated on ClinicalTrials.gov
May 15, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

North Carolina · 1

  • Duke University Medical Center · Durham, NC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.